Divisional Directors Appointed At Keighley Labs
Keighley Labs' new Divisional Directors (left-right) David Wright, Michael Emmott and Matthew Mellor

News

Divisional Directors Appointed At Keighley Labs

25 Aug, 2012

Published over 13 years ago. See the latest and most current information on News.

Keighley Laboratories, a leading company in the analysis, testing and heat treatment of metals, has appointed three of its long-serving managers to Divisional Directors, in recognition of their contribution to past performance and their key roles in future growth plans.

Together clocking up almost a hundred year’s work experience with the West Yorkshire firm, Michael Emmott becomes Divisional Commercial Director for the Heat Treatment Division, Matthew Mellor is now Divisional Technical Director responsible for the Technical Services Division, including the test house, machine shop and chemical laboratory, while David Wright has been named Divisional Production Director for the Heat Treatment Division.

“We are entering an important new phase for the company, especially with the opening of our latest production facility this year, and these promotions were designed to help restructure the senior management team, to lead the company forward,” says MD Debbie Mellor. “By assuming greater responsibility, each new Divisional Director will have ownership of his respective area and the capacity to implement strategic changes, instigate further process improvements and ensure our continued market progress.”

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Precision by weight: The critical role of gravimetric blending in fuel certification
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow